Voluven, A New Colloid Solution
As the Voluven molecule is smaller than those of other available hydroxyethyl starch products, it is associated with less plasma accumulation and can be safely used in patients with renal impairment.
You may also like
Optimizing Venous Drainage Using an Ultrasonic Flow Probe on the Venous Line
The use of smaller cannulae for minimally invasive surgery techniques and/or aggressive miniaturization of the cardiopulmonary bypass (CPB) circuitry has necessitated the need to augment venous drainage to achieve adequate flow rates.
1 min read
Coronary Bypass Safe in Patients With Low Ejection Fraction
SAN FRANCISCO (Reuters Health) – Patients with coronary artery disease and severely impaired left ventricular ejection fraction can still benefit from coronary […]
1 min read